Ipek Erdogan-Trinkaus sold $236K of ETON stock
By AlphaYouPublished Form 4
Erdogan-Trinkaus Ipek
Reporting filer
Ipek Erdogan-Trinkaus reported selling 3,500 shares of Eton Pharmaceuticals, Inc. for about $236K ($67.41 a share on average). Form 4 filed Nov 12, 2026 lists 4 entries.
See the price move since this trade →
- Disclosed
- Nov 12, 2026
Reported details
4 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Erdogan-Trinkaus Ipek | 2026-11-10 | M | Exercise or conversion | 3500 | 15.47 | 7,581 | 2 days | Filed terms
|
| Common Stock | Erdogan-Trinkaus Ipek | 2026-11-10 | S | Sale | 2340 | 67.1787 | 5,241 | 2 days | Filed terms
|
| Common Stock | Erdogan-Trinkaus Ipek | 2026-11-10 | S | Sale | 1160 | 67.8785 | 4,081 | 2 days | Filed terms
|
| Employee Stock Option (derivative) | Erdogan-Trinkaus Ipek | 2026-11-10 | M | Exercise or conversion | 3500 | 0 | 37,155 | 2 days | Filed terms
|
Common Stock
- Owner
- Erdogan-Trinkaus Ipek
- Date
- 2026-11-10
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 3500
- Price
- 15.47
- Following holdings
- 7,581
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-10
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Shares: 3500
- transaction Price Per Share: 15.47
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 7581
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Erdogan-Trinkaus Ipek
- Date
- 2026-11-10
- Code
- S
- Action
- Sale
- Quantity
- 2340
- Price
- 67.1787
- Following holdings
- 5,241
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-10
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 2340
- transaction Price Per Share: 67.1787
- id: F2
- id: F3
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 5241
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Erdogan-Trinkaus Ipek
- Date
- 2026-11-10
- Code
- S
- Action
- Sale
- Quantity
- 1160
- Price
- 67.8785
- Following holdings
- 4,081
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-10
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 1160
- transaction Price Per Share: 67.8785
- id: F2
- id: F4
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 4081
- direct Or Indirect Ownership: D
Employee Stock Option (derivative)
- Owner
- Erdogan-Trinkaus Ipek
- Date
- 2026-11-10
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 3500
- Price
- 0
- Following holdings
- 37,155
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Employee Stock Option
- conversion Or Exercise Price: 15.47
- transaction Date: 2026-11-10
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Shares: 3500
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- exercise Date: 2026-01-12
- expiration Date: 2030-01-11
- id: F1
- underlying Security Title: Common Stock
- underlying Security Shares: 3500
- shares Owned Following Transaction: 37155
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Erdogan-Trinkaus Ipek: Chief Commercial Officer.
- F1: The shares subject to the option vest in 48 equal monthly installments from the date of grant (1-12-2026) until fully vested and exercisable on January 12, 2030.
- F2: The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- F3: The shares were sold in multiple trades at prices ranging from $66.645 to $67.62. The price reported above reflects the weighted average sales price.
- F4: The shares were sold in multiple trades at prices ranging from $67.6825 to $68.075. The price reported above reflects the weighted average sales price.
Original sources
Prepared automatically from public filing data. Report a correction.